Skip to main content
. 2020 Jan 4;37(2):347–357. doi: 10.1007/s10815-019-01677-6

Table 3.

In vitro maturation and embryology outcomes

Oocyte developmental outcomes CAPA-IVM (N = 40) Standard IVM (N = 40) Between-group difference (95% CI)a p valueb
Number of COCs 17.5 [11.0, 23.0] 16.5 [9.8, 21.0] 1 (− 3, 7) 0.39
% Maturation (MII) 63.6 [55.0, 75.0] 49.0 [35.9, 62.1] 14.6 (5.5, 24) < 0.001
% Pronuclear stage per ICSI 84.0 [72.9, 100.0] 84.50 [72.0, 100.0] − 0.5 (− 10.7, 11.9) 0.80
% Grade 1 or 2 embryos per pronuclear stage 37.5 [23.8, 50.0] 35.40 [16.4, 50.0] 2.1 (− 11.5, 14.6) 0.60
% Grade 1 or 2 embryos per metaphase II 30.0 [13.9, 43.3] 26.80 [14.3, 40.7] 3.2 (− 8.6, 16.2) 0.70
% Grade 1 or 2 embryos per COC 18.9 [8.5, 26.9] 12.7 [7.3, 20.4] 6.2 (− 1.5, 12.4) 0.11
No embryo, n (%) 1 (25) 1 (25)
Frozen embryos remaining after first ET, n 2.5 ± 2.5 1.3 ± 1.9 0.02

Values are median [interquartile range], number of patients (%), mean ± standard deviation, or difference (95% confidence interval)

CAPA capacitation culture, CI confidence interval, COC cumulus-oocyte complex, EQ1 day 3 embryo quality grade 1, EQ2 day 3 embryo quality grade 2, ICSI intracytoplasmic sperm injection, IQR interquartile range, IVM in vitro maturation

aBootstrapping and resampling 1000 times

bWilcoxon rank sum test p value